Lucas Blanchard

683 total citations · 1 hit paper
9 papers, 307 citations indexed

About

Lucas Blanchard is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Lucas Blanchard has authored 9 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Lucas Blanchard's work include Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (3 papers) and Immune cells in cancer (3 papers). Lucas Blanchard is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Immunotherapy and Immune Responses (3 papers) and Immune cells in cancer (3 papers). Lucas Blanchard collaborates with scholars based in United States, France and Israel. Lucas Blanchard's co-authors include Jean‐Philippe Girard, Nathalie Ortéga, Fanny Lafouresse, Frédéric Martins, Jean‐Yves Scoazec, Caroline Robert, Séverine Le Roy, S. Bettini, Isabelle Girault and Krystle Veerman and has published in prestigious journals such as Cancer Cell, Cancer Research and Cancer Immunology Research.

In The Last Decade

Lucas Blanchard

8 papers receiving 305 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy

2022 162 citations Lucas Blanchard, Elisabeth Bellard et al. Cancer Cell profile →

Peers

Lucas Blanchard

IMMUN

ONCOL

MB

PRM

CR

Loïc Steiner Sweden

Sundee Dees United States

Arianna Draghi Denmark

Corey Gallen United States

Ziwen Yu China

Christian Avalos United States

Merel van Gogh Switzerland

Tyler G. Searles United States

Dina Morein Israel

Loïc Steiner Sweden

Lucas Blanchard

157 ×0.8

IMMUN

100 ×0.6

ONCOL

102 ×1.0

MB

49 ×1.7

PRM

39 ×1.4

CR

Citations per year, relative to Lucas Blanchard Lucas Blanchard (= 1×) peers Loïc Steiner

Countries citing papers authored by Lucas Blanchard

Since Specialization

Citations

This map shows the geographic impact of Lucas Blanchard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucas Blanchard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucas Blanchard more than expected).

Fields of papers citing papers by Lucas Blanchard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucas Blanchard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucas Blanchard. The network helps show where Lucas Blanchard may publish in the future.

Co-authorship network of co-authors of Lucas Blanchard

This figure shows the co-authorship network connecting the top 25 collaborators of Lucas Blanchard. A scholar is included among the top collaborators of Lucas Blanchard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucas Blanchard. Lucas Blanchard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Blanchard, Lucas, et al.. (2025). Fc-optimized anti-CTLA-4 antibodies increase tumor-associated high endothelial venules and sensitize refractory tumors to PD-1 blockade. Cell Reports Medicine. 6(6). 102141–102141.

2.

Osorio, Juan C., David A. Knorr, Polina Weitzenfeld, et al.. (2025). Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancer. Cancer Cell. 43(10). 1902–1916.e9. 2 indexed citations

3.

Osorio, Juan C., Lucas Blanchard, Ning Yao, et al.. (2025). Abstract CT203: Fc-optimized anti-CD40 agonist antibody 2141-V11 for BCG-unresponsive non-muscle invasive bladder cancer: Updates on phase 1 study clinical outcomes and biological correlatives. Cancer Research. 85(8_Supplement_2). CT203–CT203. 1 indexed citations

4.

Blanchard, Lucas, et al.. (2025). Targeting Myeloid Cells for Cancer Immunotherapy. Cancer Immunology Research. 13(11). 1700–1715. 1 indexed citations

5.

Osorio, Juan C., Jeffrey L. Wong, David A. Knorr, et al.. (2024). Abstract CT086: Phase I study of intravesical Fc-optimized anti-CD40 agonist antibody 2141-V11 for non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG) therapy. Cancer Research. 84(7_Supplement). CT086–CT086. 1 indexed citations

6.

Knorr, David A., Lucas Blanchard, Rom S. Leidner, et al.. (2023). FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment. Cancer Immunology Research. 12(3). 322–333. 18 indexed citations

7.

Blanchard, Lucas, Elisabeth Bellard, Krystle Veerman, et al.. (2022). Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy. Cancer Cell. 40(3). 318–334.e9. 162 indexed citations breakdown →

8.

Blanchard, Lucas, S. Bettini, Krystle Veerman, et al.. (2022). Flow cytometry analysis of endothelial cells and subsets of exhausted CD8+ T cells in murine tumor models. STAR Protocols. 3(2). 101444–101444. 5 indexed citations

9.

Blanchard, Lucas & Jean‐Philippe Girard. (2021). High endothelial venules (HEVs) in immunity, inflammation and cancer. Angiogenesis. 24(4). 719–753. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact